Comparing Docosahexaenoic Acid (DHA) Concomitant With Neoadjuvant Chemotherapy Versus Neoadjuvant Chemotherapy Alone in the Treatment of Breast Cancer (DHA WIN): Protocol of a Double-Blind, Phase II, Randomised Controlled Trial

BMJ Open - United Kingdom
doi 10.1136/bmjopen-2019-030502
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

BMJ

Related search

Neoadjuvant Chemotherapy in Breast Cancer

English

Neoadjuvant Chemotherapy: Role in Breast Cancer

2013English

Neoadjuvant Chemotherapy in the Treatment of Cervical Cancer

2012English

Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer

Journal of Medical – Clinical Research & Reviews
2019English

Neoadjuvant Chemotherapy in the Combined Treatment of Gastric Cancer

Onkologiya. Zhurnal imeni P.A.Gertsena
2014English

Local Radiotherapy Alone Following Neoadjuvant Chemotherapy and Surgery in Combined Clinical Stage II and III Breast Cancer

Radiation Oncology
Nuclear MedicineRadiologyImagingOncology
2016English

BACCHUS: A Randomised Non-Comparative Phase II Study of Neoadjuvant Chemotherapy (NACT) in Patients With Locally Advanced Rectal Cancer (LARC)

Heliyon
Multidisciplinary
2018English

Predictors of Tumor Progression During Neoadjuvant Chemotherapy in Breast Cancer

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2010English

Neoadjuvant Chemotherapy for Early Breast Cancer – Author's Reply

The Lancet Oncology
Oncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy